Skip to main content
Get Matched with a Provider
Medication

Trazodone

Trazodone is a prescription antidepressant that belongs to the class of serotonin modulators. Originally developed to treat depression, it is also widely prescribed off-label for sleep problems such as insomnia because of its sedative properties.

Learn About Trazodone Treatment

Connect with a psychiatric clinician—online or in person—for a comprehensive evaluation. If appropriate, they may discuss whether trazodone could be part of your treatment plan.

Schedule an appointment with a Psychiatric Clinician

What Conditions Does Trazodone Treat?

FDA-Approved Uses:

Common Off-Label Uses:

How Psychiatric Medication Prescription Decisions Are Made

1

Find a psychiatric clinician who meets your needs

Option 1

You can start by searching our psychiatrist directory to find a qualified provider who is accepting patients.

Provider Directory

Option 2

You may also choose to locate a nearby clinic and schedule your first appointment in person.

Locations Directory
2

Step 2: Meet one-on-one for a comprehensive psychiatric evaluation

During your first session, a psychiatric clinician will evaluate your symptoms, medical history, and treatment goals. If appropriate, they may discuss whether a medication such as trazodone could be included in your care plan. Treatment decisions always prioritize safety, clinical best practices, and your individual needs.

3

Step 3: Begin treatment and ongoing monitoring

After a personalized treatment plan is created, your provider will monitor your progress and adjust the plan as needed. If medication is part of your care, then, if clinically appropriate, your provider may handle prescription renewals online during or after regular follow-ups as clinically appropriate in accordance with LifeStance treatment protocols.

240+ Insurances Accepted

Aetna
Anthem/Empire BCBS-Medicare, Anthem Blue Cross, Anthem/Empire BCBS, Anthem Blue Cross-Medicare, Anthem BCBS-Medicare, Anthem BCBS
Blue Cross Blue Shield (BCBS)
CareFirst BlueCross BlueShield, CareFirst BlueCross BlueShield-Medicare
Evernorth (Cigna), Evernorth (Cigna) (HealthPartners), Evernorth (Cigna)-Medicare
Highmark Blue Cross Blue Shield, Highmark Blue Shield, Highmark Blue Shield-Medicare, Highmark Blue Cross Blue Shield-Medicare
Kaiser Permanente (Southeast)-Medicare, Kaiser Permanente Washington-Medicare, Kaiser Permanente (SoCal)-Medicare, Kaiser Permanente (Southeast), Kaiser Permanente Washington, Kaiser Permanente (SoCal), Kaiser Permanente (Northwest), Kaiser Permanente (Northwest)-Medicare
Medicare
Optum, UnitedHealthcare, Optum, UnitedHealthcare-Medicare
Providence Health Plan, Providence Health Plan-Medicare
Quartz, Quartz-Medicare
Quest Behavioral Health
Regence BlueCross BlueShield, Regence BlueCross BlueShield-Medicare
Struggling with Depression?

Struggling with Depression?

Everyone’s experience with depression is different. A psychiatrist may help you find the right treatment path—whether that includes Trazodone or another option that fits your needs. Discuss medication options with your treating provider.

Psychiatric Clinician Directory

FAQs About Trazodone

Trazodone is FDA-approved to treat major depressive disorder (MDD). It is also widely prescribed off-label for insomnia because of its sedative effects.

Trazodone is a serotonin modulator. It increases serotonin activity by blocking reuptake and altering serotonin receptor function. This dual action helps improve mood, reduce anxiety, and promote sleep.

Trazodone is not classified as an SSRI (selective serotonin reuptake inhibitor). However, it is a serotonin antagonist and reuptake inhibitor (SARI), which means it blocks serotonin reuptake like an SSRI and also directly affects serotonin receptors.

Most common side effects of trazodone are:

  • Drowsiness and fatigue: Trazodone has strong sedative effects and is often used off-label to treat insomnia. Drowsiness is the most common side effect and may affect alertness for driving or operating machinery.
  • Dizziness or lightheadedness: This can occur due to orthostatic hypotension (a drop in blood pressure when changing positions). It is more common in older adults.
  • Dry mouth: A very common anticholinergic side effect. Chewing sugar-free gum or sucking on ice chips may help manage this symptom.
  • Headache: Mild to moderate headaches are a common adverse effect.
  • Gastrointestinal issues: Nausea, vomiting, diarrhea, and constipation are frequently reported. Taking this medication with food can help reduce nausea.
  • Nasal congestion: A stuffy nose or sinus congestion can occur.
  • Blurred vision: A less common, but still reported, side effect.
  • Changes in appetite or weight: Some people experience weight loss or weight gain, from a change in appetite. The effect on weight can vary between individuals.

Yes. Trazodone often causes drowsiness, which is why it is commonly prescribed off-label for insomnia. Many individuals fall asleep faster and stay asleep longer when taking it before bedtime.

Trazodone has a half-life of about 5 to 9 hours, meaning it remains in the body overnight and can sometimes cause grogginess or a “hangover effect” the next morning.

While not FDA-approved specifically for insomnia, trazodone is one of the most commonly prescribed sleep medications. It can help people fall asleep, stay asleep, and experience deeper rest.

Some people report weight gain with trazodone, while others experience no change or even weight loss. Weight changes can be due to increased appetite, reduced activity from sedation, or changes in metabolism. If you notice significant weight changes, discuss them with your clinician.

Like many antidepressants, trazodone may cause sexual side effects such as decreased desire, delayed orgasm, or erectile difficulties. However, patients are less likely to experience sexual side effects on trazodone compared to SSRIs. Very rarely, trazodone can cause priapism in men, which is a medical emergency involving dangerous penial blood flow changes and characterized by a spontaneous erection that does not subside on its own. Your provider may discuss other medication options with you if sexual side effects become a concern.

Trazodone is not known for being addictive when taken as prescribed by a clinician. It is not a controlled substance. However, stopping suddenly may cause withdrawal-like symptoms such as anxiety or difficulty sleeping.

Improvements in mood may take 4 to 6 weeks. For sleep, most people feel the effects the first night they take it.

Trazodone may be prescribed long-term under medical supervision, but it is usually prescribed when patients have depression, anxiety, or other conditions in addition to insomnia. Long-term use should be monitored for side effects such as grogginess, low blood pressure, or irregular heartbeat.

Avoid alcohol, sedatives, driving, and operating heavy machinery until you know how trazodone affects you. Combining it with other substances that cause drowsiness can be dangerous.

Trazodone can interact with other antidepressants, migraine medications, blood thinners, antifungal drugs, and sedatives. Consult your prescribing clinician before starting, stopping, or combining any medications or substances with trazodone.

Trazodone is available in generic form. As of publication date, the price per tablet typically starts at around $0.25 to $0.40 depending on the strength and quantity purchased. For most prescriptions, a 30-day supply averages between $8 and $20 without insurance. The exact cost may vary based on dosage strength, pharmacy, and whether you use coupons or insurance coverage.

If you have insurance, your out-of-pocket cost will depend on your supporting diagnosis and plan type (e.g., commercial, Medicare, Medicaid) and may include a copay or coinsurance.

While not FDA-approved for anxiety, trazodone can have calming effects that help reduce anxiety symptoms, especially when anxiety is combined with sleep problems.

Trazodone is an antidepressant often prescribed off-label for sleep, while Ambien (zolpidem) is a sedative-hypnotic specifically approved for insomnia. Ambien usually acts faster, but it carries a higher risk of dependence and tolerance (reduced effect over time). Trazodone may be used long-term under medical supervision, is not likely to cause tolerance, but may lead to next-day grogginess.

Trazodone is an antidepressant with sedative properties. Xanax (alprazolam) is a benzodiazepine used for anxiety and panic disorders. Xanax works quickly but has a high risk of dependence, while trazodone is not known for being addictive and is more commonly prescribed for depression and sleep issues.

No. Trazodone is an antidepressant, while tramadol is an opioid pain reliever. They have different uses and risks. Both can cause drowsiness and combining them may increase the risk of serotonin syndrome or other side effects.

Trazodone is often prescribed for both depression and insomnia, while hydroxyzine is an antihistamine sometimes used for anxiety and sleep. Hydroxyzine tends to cause more next-day drowsiness, while trazodone is usually prescribed when long-term treatment for mood or sleep issues is needed.

Both are antidepressants that can cause sedation and may be prescribed for sleep problems. Mirtazapine often causes more weight gain and appetite increase, while trazodone may cause fewer metabolic side effects but can cause morning grogginess. Choice depends on individual needs and side effect tolerability.

Trazodone is an antidepressant often used off-label for sleep, while Lunesta (eszopiclone) is an FDA-approved sleep aid. Lunesta is usually prescribed for short-term insomnia, and it carries a higher risk of dependence and tolerance (reduced effect over time). Trazodone may be used long-term under medical supervision, is not likely to cause tolerance, but may lead to next-day grogginess.

Trazodone is a serotonin modulator, while Zoloft (sertraline) is an SSRI. Both treat depression, but Zoloft is also FDA-approved for anxiety disorders, PTSD, OCD, and panic disorder. Trazodone is more sedating, which may make it more useful for patients with depression and insomnia.

Medically Reviewed By:

Joshua Nathan, MD
View Profile
Dr. Joshua Nathan, a Board-Certified Psychiatrist, and a Distinguished Fellow of the American Psychiatric Association, sees stigma – from others and from ourselves - as the biggest challenge in mental illness treatment. He encourages people to not judge themselves on whatever problems they are facing, and he helps them feel safe to open up and allow for healing. Dr. Nathan takes joy in helping people with mental health concerns and values the trust patients place in him. Dr. Nathan treats adults struggling with mood and bipolar disorders, depression, ADHD, anxiety challenges such as panic disorder, agoraphobia, OCD, PTSD, and more. He listens to each person’s story, observes how they are faring, and shares his understanding of what is happening, so there is a basis for starting or continuing treatment. He considers medications as one tool among many for healing and recovery in mental health. During treatment, Dr. Nathan uses an eclectic framework for understanding mental illness and coping. Trained in psychoanalysis, he finds that existential understanding helps many people reduce suffering, but cognitive-behavioral techniques are more practical in helping people move forward. Thus, he typically employs a combination of theories and techniques, guided by the patient's problems, needs, and experiences. He is also an Official ADHD Evaluator for the National Football League. Dr. Nathan earned an undergraduate degree from the University of Illinois at Urbana-Champaign, a medical doctorate from the University of Illinois at Chicago, and completed postgraduate residency training at Brown University. He works with adults of all ages, but has a special fondness for working with young and middle-age adults.

References

  1. Drugs.com. (n.d.). Trazodone prices, coupons, copay cards & patient assistance. Retrieved November 24, 2025, from https://www.drugs.com/price-guide/trazodone

  2. Pfeffer, C. R. (2007). The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression. American Journal of Psychiatry, 164(6), 843-846. https://doi.org/10.1176/ajp.2007.164.6.843

  3. U.S. Food & Drug Administration. (n.d.). Drugs@FDA database. Retrieved November 24, 2025, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm

In 2007, the FDA released a black box warning that antidepressants were correlated to the risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18–24) during short-term studies of major depressive disorder (MDD) and other psychiatric conditions. Gibbons et. al (2007) also published a study that found no evidence of antidepressant treatment increasing the risk of suicide attempts among its patients (ages 18-65+). The main message is that there is an inherent relationship between depression and suicidality so close monitoring of antidepressant-treated patients (especially children, adolescents, and young adults) is always necessary. For a comprehensive overview of these medications’ uses and risks, see the U.S. Food and Drug Administration (FDA) drug label.